Insider Transactions in Q4 2020 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,800
+7.01%
|
$13,800
$1.81 P/Share
|
|
Dec 21
2020
|
Tony W Ho Executive VP, Head of R&D |
SELL
Open market or private sale
|
Direct |
23,551
-5.54%
|
$3,509,099
$149.69 P/Share
|
|
Dec 21
2020
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
23,551
+29.05%
|
$376,816
$16.9 P/Share
|
|
Dec 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
7,352
-0.43%
|
$1,095,448
$149.12 P/Share
|
|
Dec 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
7,648
-50.79%
|
$1,139,552
$149.12 P/Share
|
|
Dec 10
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
33,000
-1.97%
|
$4,686,000
$142.54 P/Share
|
|
Dec 10
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-2.2%
|
$2,840,000
$142.92 P/Share
|
|
Dec 10
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.56%
|
$20,000
$1.81 P/Share
|
|
Dec 09
2020
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
22,026
+49.56%
|
$286,338
$13.62 P/Share
|
|
Dec 07
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
171,004
-2.08%
|
$26,334,616
$154.02 P/Share
|
|
Dec 01
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-0.46%
|
$100,491
$129.58 P/Share
|
|
Nov 30
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
100,000
-7.16%
|
$12,500,000
$125.0 P/Share
|
|
Nov 30
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+6.68%
|
$1,400,000
$14.22 P/Share
|
|
Oct 29
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
18,477
+31.25%
|
-
|
|
Oct 29
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
518,519
-49.0%
|
-
|
|
Oct 29
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
105,681
+50.0%
|
-
|
|
Oct 09
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
2,762
-0.42%
|
$276,200
$100.0 P/Share
|
|
Oct 09
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+0.42%
|
$38,668
$14.43 P/Share
|
|
Oct 08
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
22,238
-3.32%
|
$2,223,800
$100.0 P/Share
|
|
Oct 08
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,238
+3.21%
|
$311,332
$14.43 P/Share
|